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Abstract 
 The increasing presence of drug resistant bacteria has led to research of new methods to 
combat bacteria.  A part of the natural peptide Lactoferricin, LfB6 (RRWQWR-NH2), has been 
shown to be effective against a variety of gram positive and gram negative bacteria.  However, 
there are several problems associated with peptides.  Peptides can quickly degrade in the body 
which causes larger doses to be effective.  Large doses of some peptides are cytotoxic to the 
host.  Peptoids are a class of compounds that can potentially mimic the function of peptides and 
circumvent the problems associated with them.  The backbone of peptoids is similar to that of 
peptides but functional groups are bonded to nitrogen instead of the alpha-carbon.  Peptoids are 
protease resistant, which allows for lower dosages while retaining equal effectiveness.  This 
research strives to make the peptoid compliment of LfB6, N-LfB6, and determine the 
effectiveness of N-LfB6 as an antimicrobial agent.  The peptoid N-LfB6 has been synthesized 
and purified.  Future research will determine the effectiveness of the peptoid against bacteria. 
Research into N-LfB6 could prove to be valuable in terms of antimicrobial effectiveness, 
stability, and low cytotoxicity to the body.   
 
Introduction  
 Bacterial infections are a commonplace in today’s world.  Many bacterial strains are 
becoming drug resistant, making it more difficult to treat infections.  The increase of these drug 
resistant bacteria has led to the research into new methods to defend against bacteria.  This has 
opened up the study for naturally occurring antimicrobial peptides (AMPs) (1,2).  However, the 
use of peptoids, poly-N-substituted glycines, could prove to be more effective at killing bacteria.  
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The goal of this research is to synthesize the peptoid compliment of the AMP LfB6 and to 
determine its effectiveness as an antimicrobial agent. 
 
Background 
 AMPs are a naturally occurring defense mechanism in multicellular organisms. They are 
effective against a broad spectrum of both gram-positive and gram-negative bacteria.  For this 
reason, they can provide an alternative to traditional antibiotics.  AMPs kill bacteria by attacking 
the bacterial cell wall.  The bacterial cell wall is composed of many negatively charged 
phospholipids heads with a hydrophobic core.  AMPs typically contain a combination of 
positively charged and hydrophobic side chains.  The interaction of the AMP with the cell wall 
causes degradation and perforation to the cell wall which ultimately causes death to the bacterial 
cell (7).    
 Though effective antimicrobial agents, AMPs have problems associated with their use.  
AMPs are very susceptible to proteolytic degradation, reducing the availability of AMPs to 
combat bacteria.   Because of this, it is often necessary to use high doses of AMPs to counteract 
this problem.  However, high concentrations of AMPs can be cytotoxic to the host’s body (1).   
Peptides also have problems with absorption into the body, preventing them from being readily 
available to the body (4).  The use of peptoids could help circumvent these problems.   
 Peptoids differ from peptides in that the functional group of the peptide is attached to the 
amide nitrogen instead of the α-carbon (see Figure 1).  Peptoids retain similar function to 
peptides.  This movement of the side chain to the nitrogen allows the peptoid to be protease 
resistant, increasing the bioavailability.  Research has shown that peptoids are effective against a 
wide range of gram-positive and gram-negative bacteria (1, 3).  It has also been shown that 
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peptoids exhibit less cytotoxicity than peptides. In some cases, peptoids show cytotoxicity up to 
20 times less that currently used AMPs (1).  Peptoids are easily synthesized, often using the same 
equipment used to make peptides (1).  This allows for the relative ease of the adjustment of 
peptoid side chains. Peptoids could be synthesized to have the most desired properties (3).  This 
includes adjustment of the number and type of functional groups composing the peptoid.   
 
 
Figure 1:  Comparison between peptides and peptoids (4).  
 The mechanisms for the bactericidal effects are similar to AMP however the exact 
mechanism is unknown.  It has been shown that peptoids cause a rupture within the cell 
membrane, which causes slow leakage from the cell (1, 3).  The presence of cationic functional 
groups increases this method of antimicrobial activity.  This is likely due to the interaction with 
anionic proteins found in the bacterial membrane.  Replacing a functional group on a peptoid 
with one that was cationic showed increased effectiveness in antimicrobial activity.  
Antimicrobial activity was also increased when side chains were replaced with bulky, 
hydrophobic side chains (1).   
 Lactoferricin (LfB) is a naturally occurring immunity peptide found in bovine protein 
lactoferrin.  The peptide LfB6 is considered to form the antimicrobial active site of lactofericin.  
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LfB6, RRWQWR-NH2, has been shown to be an effective AMP against a variety of bacteria (2). 
Through methylation of the second tryptophan, RRWQ[1-Me-W]R-NH2, the effectiveness of 
LfB6 is further increased three times.  LfB6 is a good candidate to make into an antimicrobial 
peptoid (N-LfB6) for many reasons.  The presence of the catatonic arginine groups will help to 
allow for antimicrobial activity.  The presence of the two tryptophan side chains was found to be 
necessary for antimicrobial activity of the peptide (2).  The bulky, hydrophobic tryptophan 
groups could help to increase the antimicrobial activity (1).  The presence of tryptophan can also 
allow the peptoid to retain secondary helical structures similar to the peptide.  Hydrogen bonding 
in peptoids is lost due to the presence of the side chain on the nitrogen, however, the presence of 
bulky, aromatic side chains could allow the peptoid to form stable helices due to steric 
interactions (4, 5).  The structure of N-LfB6 is shown in Figure 2. 
 
Figure 2:  Structure of the peptoid N-LfB6. 
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Materials and Methods  
 N-LfB6 requires the side chains NTrp, NGln, and NArg in order to be synthesized.  The side 
chains NTrp and NGln are reliably available and can be purchased.  NArg, however, must be 
synthesized.  NArg can be synthesized using a published protocol (9) with protecting groups on 
the terminal nitrogens as shown in Figure 3.  This prevents side reactions with the functional 
group when acylating with a haloacetic acid to create the backbone of the peptoid. The side chain 
can then be purified using column chromatography. Synthesis conformation can be determined 
using ESI-MS and purity is determined using H-NMR. The protecting groups are removed after 
the peptoid is synthesized. 
 
Figure 3:  NArg structure. 
 The peptoid is synthesized using an ABI 433A automated peptide synthesizer.  In this 
process, an amine on a monomer is attached to a resin. The amine then bonded to a haloacetic 
acid (bromoacetic acid).  The halogen is then replaced to bind to the amine group of a second 
monomer (6).  This process is repeated to create the peptoid as shown in Figure 4 (8).   
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Figure 4:  Synthesis of a peptoid. (8) 
 Once the peptoid is synthesized, it can be separated from the resin using acid.  The excess 
solvents can then be removed using a lyophilizer.  The desired peptoid purified using preparative 
HPLC using a gradient of acetonitrile and water (5-95%) in conjunction with a C18 column. The 
mass and purity is determined using MALDI.     
 Antimicrobial investigation will be conducted using a microtitre broth dilution method 
modified by Denise Greathouse.  Effectiveness against both gram-positive bacteria (Bacillus 
subtilis) and gram-negative bacteria (Escherichia coli) will be tested. 
 
Results  
 The side chain NArg was successfully synthesized.  The estimated molecular weight of 
330.4 was found using ESI-MS as shown in Figure 5.  The side chain was then purified using 
column chromatography.  The H-NMR shown in Figure 6 matches the estimation for the side 
chain structure. 
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Figure 5:  ESI-MS of NArg synthesis. 
 
Figure 6:  NMR of NArg. 
 The peptoid N-LfB6 (Figure 2) was successfully synthesized.  The desired molecular 
weight of 1057.7 was confirmed using MALDI (Figure 7).  The peptoid was purified using 
N-Arg 
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preparative HPLC.  Analytical HPLC (Figure 8) along with mass spectroscopy shows the peptoid 
to be 97% pure. 
 
Figure 7:  MALDI-MS of synthesized N-LfB6. 
 
Figure 8:  Analytical HPLC results of purified peptoid. 
 
N-LFB6 
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Conclusion  
 The peptoid N-LfB6 was successfully synthesized and purified.  Further investigation 
into the effectiveness of N-LfB6 is needed.  Specifically, the effectiveness of N-LfB6 as an 
antimicrobial peptoid will be determined via microtitre bacterial assays.  LfB6 has been shown to 
be an effective AMP both with and without the methylated tryptophan.  The effective functional 
group sequence coupled with the benefits of a peptoid could allow N-LfB6 to be a new, effective 
antibacterial agent.   
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